september

NYSE Content Advisory: Pre-Market update + Mike Waltz, U.S. Ambassador to UN, rings Opening Bell

NEW YORK, Sept. 22, 2025 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from…

1 month ago

Lamborghini narrowly misses out on GT World Challenge Europe title in Valencia

GRT pairing Pepper and Engstler take runner-up spot in Sprint Cup despite giving Huracán GT3 197th win in opening race…

1 month ago

Vocalbeats.AI Strengthens Commitment to AI Advancement as Sponsor of Singapores FutureChina Global Forum 2025

September 22, 2025 05:30 ET  | Source: Vocalbeats FutureChina Global Forum 2025 convened leaders from more than 25 countries, with…

1 month ago

AIMA Technology and Pakistan-based New Asia Enter into a Strategic Partnership to Jointly Explore New Blue Ocean Opportunities in Green Mobility

BEIJING, Sept. 22, 2025 /PRNewswire/ -- The 2nd Pakistan-China B2B Investment Conference was grandly held in Beijing on September 4.…

1 month ago

Framatome launches operations in India

MUMBAI, India  , Sept. 22, 2025 /PRNewswire/ -- Framatome inaugurated its India operations base in Navi Mumbai on September 17, in the…

1 month ago

IOC Executive Board approves 13 athletes changes of sporting nationality for the Milano Cortina 2026 Olympic Winter Games

19 September 2025 - Today, during the second day of its meeting in Milan, the International Olympic Committee (IOC) Executive Board (EB)…

1 month ago

IOC reaffirms: Sport must unite the world in peaceful competition

19 September 2025 - In a world shaken by conflict and division, the International Olympic Committee (IOC) Executive Board (EB) stands firm in…

1 month ago

REPL Deadline: Rosen Law Firm Encourages Replimune Group, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important September 22 Deadline in Securities Class Action First Filed by the Firm REPL

NEW YORK--(BUSINESS WIRE)--Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Replimune Group, Inc.…

1 month ago

C4 Therapeutics Presents Cemsidomide Phase 1 Multiple Myeloma Data Supporting Potential Best-in-Class Profile at the International Myeloma Society Annual Meeting

September 20, 2025 11:00 ET  | Source: C4 Therapeutics, Inc. Cemsidomide in Combination With Dexamethasone Achieved a 50% Overall Response…

2 months ago

French Alps 2030 progress picks up pace ahead of handover from Milano Cortina 2026 Coordination Commission named

19 September 2025 - French Alps 2030 Organising Committee President Edgar Grospiron and CEO Cyril Linette presented by video conference a progress update…

2 months ago